<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02411266</url>
  </required_header>
  <id_info>
    <org_study_id>2008 0406 II</org_study_id>
    <nct_id>NCT02411266</nct_id>
  </id_info>
  <brief_title>Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage</brief_title>
  <acronym>PreLIMBS</acronym>
  <official_title>Remote Ischemic Preconditioning to Ameliorate Delayed Ischemic Neurological Deficit After Aneurysmal Subarachnoid Hemorrhage: a Safety and Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn about protecting the brain from dangerous low blood&#xD;
      flow.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 30, 2008</start_date>
  <completion_date type="Actual">December 8, 2020</completion_date>
  <primary_completion_date type="Actual">December 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety Outcomes 1 - number of patients who develop deep vein thrombosis and thromboembolism</measure>
    <time_frame>90 days</time_frame>
    <description>The number of patients who develop deep vein thrombosis and thromboembolism in the treatment and control group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Outcome 2 - number of patients who develop neurovascular injury</measure>
    <time_frame>90 days</time_frame>
    <description>The number of patients who develop neurovascular injury in the treatment and control group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Outcome 3 - number of patients who cannot tolerate the intervention due to discomfort</measure>
    <time_frame>90 days</time_frame>
    <description>The number of patients who cannot tolerate the intervention due to discomfort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Outcome 4 - number of patients with cardiovascular events</measure>
    <time_frame>90 days</time_frame>
    <description>The number of patients with cardiovascular events [defined as hypotension, myocardial ischemia]</description>
  </primary_outcome>
  <other_outcome>
    <measure>Clinical Outcome - number of patients with a good modified Rankin Scale, defined as less than 2</measure>
    <time_frame>90 days</time_frame>
    <description>The number of patients with a good modified Rankin Scale, defined as less than 2, in the control and intervention group.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Ischemic Preconditioning</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects in this group will undergo sham preconditioning. A blood pressure cuff will be placed around the leg and inflated just lightly to a pressure of 30mmHg, not enough to affect arterial circulation. This will be maintained for 10min followed by 5min of deflation. This will constitute one conditioning cycle. There will be 3 sham conditioning cycles per treatment session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>treatment group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study personnel will place a blood pressure cuff around the subject's leg and use it to interrupt the circulation to the leg for 10 minutes followed by release of the blood pressure for 5 minutes. This will be repeated for a total of 3 times every 24 to 48 hours up to 14 days. The cuff will be inflated for 10 minutes and then deflated for 5 minutes. There will be 3 cycles of this. The cuff will be inflated to 200mmHg to induce ischemia, confirmed by palpation of pedal pulses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ischemic conditioning group</intervention_name>
    <description>application of a blood pressure cuff around a leg and inflating the cuff to 200mmHg to induce limb ischemia for 10min followed by 5min reperfusion. this will be done for 3 cycles every 24-48hours during the first 14 days after subarachnoid hemorrhage</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>treatment group</arm_group_label>
    <other_name>limb preconditioning</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with aneurysmal subarachnoid hemorrhage whose initial angiogram show an&#xD;
             aneurysm and patients with clipped aneurysm will be eligible for enrollment.&#xD;
&#xD;
          -  Patients will be enrolled within 96 hours of bleeding onset, if informed consent is&#xD;
             obtained from the participant or health care proxy, as appropriate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hunt Hess Scale &gt; 4&#xD;
&#xD;
          -  Inability to undergo limb preconditioning due to local wound or tissue breakdown,&#xD;
             history of peripheral extremity vascular disease or patient discomfort.&#xD;
&#xD;
          -  Inability to obtain informed consent from the patient or a health care proxy.&#xD;
&#xD;
          -  Ankle-brachial index &lt; 0.7&#xD;
&#xD;
          -  Inability to start limb preconditioning within 4 days of bleeding.&#xD;
&#xD;
          -  Inability to precondition a leg that is not-plegic (that is preserved anti- gravity&#xD;
             strength) and has not been accessed for catheter angiography&#xD;
&#xD;
          -  Age&lt;18 years&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian Koch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2015</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Sebastian Koch</investigator_full_name>
    <investigator_title>Associate Professor of Clinical Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

